Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
Humans
Female
Adult
Breast Neoplasms
/ drug therapy
Prospective Studies
Scalp
Docetaxel
/ adverse effects
Carboplatin
/ adverse effects
Antineoplastic Combined Chemotherapy Protocols
/ adverse effects
Alopecia
/ chemically induced
Taxoids
/ adverse effects
Chemotherapy, Adjuvant
Anthracyclines
/ adverse effects
Cyclophosphamide
/ therapeutic use
Paclitaxel
/ adverse effects
Antibiotics, Antineoplastic
/ adverse effects
alopecia
breast cancer
chemotherapy
scalp cooling
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
30 09 2022
30 09 2022
Historique:
received:
30
08
2022
revised:
22
09
2022
accepted:
28
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
The prevention of chemotherapy-induced alopecia still represents an urgent need for every day clinical practice. In this regard, this prospective single-center study included breast cancer (BC) patients who underwent a scalp cooling device (Dignicap
Identifiants
pubmed: 36290846
pii: curroncol29100569
doi: 10.3390/curroncol29100569
pmc: PMC9600590
doi:
Substances chimiques
Docetaxel
15H5577CQD
Carboplatin
BG3F62OND5
taxane
1605-68-1
Taxoids
0
Anthracyclines
0
Cyclophosphamide
8N3DW7272P
Paclitaxel
P88XT4IS4D
Antibiotics, Antineoplastic
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7218-7228Références
Lancet. 2019 Apr 6;393(10179):1440-1452
pubmed: 30739743
Support Care Cancer. 2021 Nov;29(11):6943-6956
pubmed: 33847828
Psychooncology. 2008 Apr;17(4):317-28
pubmed: 17721909
Cancers (Basel). 2021 Aug 03;13(15):
pubmed: 34359815
Oncol Res Treat. 2015;38(10):489-95
pubmed: 26451590
Int J Nurs Pract. 2021 Jun;27(3):e12888
pubmed: 32959460
Dermatol Pract Concept. 2020 Jun 29;10(3):e2020074
pubmed: 32642317
N Engl J Med. 1979 Dec 27;301(26):1427-9
pubmed: 514322
Acta Oncol. 2012 Apr;51(4):497-504
pubmed: 22304489
Cancer Treat Res Commun. 2021;26:100280
pubmed: 33338853
Br J Cancer. 2019 Aug;121(4):325-331
pubmed: 31303642
Breast. 2018 Oct;41:127-132
pubmed: 30048865
JAMA. 2017 Feb 14;317(6):606-614
pubmed: 28196257
Breast Cancer Res Treat. 2019 Jan;173(1):135-143
pubmed: 30255454
Future Oncol. 2019 Oct;15(29):3337-3344
pubmed: 31578891
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Breast J. 2020 Jul;26(7):1296-1301
pubmed: 31837103
J Oncol Pract. 2018 Mar;14(3):149-154
pubmed: 29529389
An Bras Dermatol. 2020 Sep - Oct;95(5):631-637
pubmed: 32622629
Breast. 2018 Aug;40:1-3
pubmed: 29660543
N Engl J Med. 2018 Jul 12;379(2):111-121
pubmed: 29860917
Breast Cancer Res Treat. 2021 Jan;185(2):453-458
pubmed: 33125621